Humedix Co Ltd
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to H… Read more
Humedix Co Ltd (200670) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.037x
Based on the latest financial reports, Humedix Co Ltd (200670) has a cash flow conversion efficiency ratio of 0.037x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.71 Billion) by net assets (₩265.23 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Humedix Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Humedix Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Humedix Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Humedix Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Fangda Group Co Ltd
SHE:200055
|
0.006x |
|
Jiangsu Nanfang Medical
SHG:603880
|
0.048x |
|
Hubtown Limited
NSE:HUBTOWN
|
0.035x |
|
FAP Agri Tbk PT
JK:FAPA
|
0.182x |
|
Modiv Inc
NYSE:MDV
|
0.020x |
|
Golden Flower Tbk PT
JK:POLU
|
0.204x |
|
ALT5 Sigma Corporation
NASDAQ:ALTS
|
-0.006x |
|
Gaotu Techedu Inc
F:18WA
|
N/A |
Annual Cash Flow Conversion Efficiency for Humedix Co Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Humedix Co Ltd from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩228.53 Billion | ₩50.74 Billion | 0.222x | +42.39% |
| 2023-12-31 | ₩198.06 Billion | ₩30.89 Billion | 0.156x | -43.14% |
| 2022-12-31 | ₩139.11 Billion | ₩38.15 Billion | 0.274x | +80.11% |
| 2021-12-31 | ₩125.99 Billion | ₩19.18 Billion | 0.152x | -23.06% |
| 2020-12-31 | ₩120.07 Billion | ₩23.76 Billion | 0.198x | +60.66% |
| 2019-12-31 | ₩112.10 Billion | ₩13.81 Billion | 0.123x | -45.07% |
| 2018-12-31 | ₩106.13 Billion | ₩23.80 Billion | 0.224x | +176.11% |
| 2017-12-31 | ₩107.92 Billion | ₩8.77 Billion | 0.081x | +16.47% |
| 2016-12-31 | ₩109.11 Billion | ₩7.61 Billion | 0.070x | -34.59% |
| 2015-12-31 | ₩109.80 Billion | ₩11.71 Billion | 0.107x | -- |